Cowen & Co
http://www.cowen.com/default.htmlCowen and Company offers investment banking services, including equity research, equity and convertible debt financings, mergers and acquisitions advisory services, and restricted security sales.
-
Sienna Biopharmaceuticals (SNNA) Initiates Voluntary Chapter 11 Protection Proceeding
-
Sienna Biopharmaceuticals Initiates Voluntary Chapter 11 Protection Proceeding
-
Sienna Biopharmaceuticals (SNNA) to Explore Financial and Strategic Alternatives
-
Sienna Biopharmaceuticals Engages Cowen to Explore Financial and Strategic Alternatives
-
Sienna Biopharmaceuticals to Present at Cowen and Company Health Care Conference
-
Sienna Biopharmaceuticals (SNNA) Prices 8M Share Common Stock Offering at $2.50/Share
-
Sienna Biopharmaceuticals Prices Public Offering of Common Stock
-
Sienna Biopharmaceuticals (SNNA) Commences Public Offering of Common Stock
-
Sienna Biopharmaceuticals Announces Proposed Public Offering of Common Stock
-
Sienna Biopharmaceuticals (SNNA) PT Lowered to $45 at Cowen; Thesis Intact Despite Miss
-
Pre-Open Movers 07/30: (RDHL) (FDC) (CAT) Higher; (SNNA) (SOHU) (SODO) Lower (more...)
-
Sienna Biopharmaceuticals to Present at Cowen and Company Health Care Conference
-
Cowen Starts Sienna Biopharmaceuticals (SNNA) at Outperform
-
Sienna Biopharmaceuticals Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Sienna Biopharmaceuticals (SNNA) IPO Opens Sharply Higher
-
Sienna Biopharmaceuticals (SNNA) Prices 4.33M Share IPO at $15/Sh
-
Sienna Biopharmaceuticals, Inc. Announces Pricing of Initial Public Offering of Common Stock

